Home/Filings/4/0001566049-19-000006
4//SEC Filing

Payne Joseph E 4

Accession 0001566049-19-000006

CIK 0001566049other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 4:21 PM ET

Size

5.4 KB

Accession

0001566049-19-000006

Insider Transaction Report

Form 4
Period: 2019-02-07
Payne Joseph E
President and CEO10% Owner
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2019-02-07$4.99/sh+60,000$299,40060,000 total
    Exercise: $4.99Exp: 2029-02-06Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The grant of options to the Reporting Person is subject to shareholder approval under the Companies Law 5759-1999 of the State of Israel; options vest over a period of four years from Vest Base Date, with 25% of the options vesting on the first anniversary thereof and the remainder vesting in equal monthly installments thereafter.

Issuer

Arcturus Therapeutics Ltd.

CIK 0001566049

Entity typeother

Related Parties

1
  • filerCIK 0001727315

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 4:21 PM ET
Size
5.4 KB